Skip to main content
Log in

In vitro activity of biapenem against beta-lactamase producingEnterobacteriaceae

  • New Antimicrobial Agents
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The activity of biapenem was compared with that of imipenem and cefotaxime against 108 strains of β-lactamase producingEnterobacteriaceae. Biapenem and imipenem were very active, inhibiting 90 % of the strains at a concentration of 0.5 µg/ml. Both carbapenems were very active against plasmidic β-lactamase producers, with MIC90s below 1 µg/ml. However, the MIC90 of biapenem for cephalosporinase producers was 1 µg/ml. Against strains producing extended-spectrum β-lactamases, biapenem exhibited better activity against TEM-type producers (MIC90 0.25 µg/ml) than against SHV-type producers (MIC90 0.5 µg/ml). Overall, the in vitro antibacterial activity of biapenem is similar to that of imipenem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A2. NCCLS, Villanova, PA, 1990.

    Google Scholar 

  2. Matthew M, Harris AM, Marshall MJ, Ross GW: The use of analytical isoelectric focusing for detection and identification of β-lactamases. Journal of General Microbiology 1975, 88: 169–178.

    PubMed  Google Scholar 

  3. Papanicolaou GA, Medeiros AA: Discrimination of extended spectrum β-lactamases by a novel nitrocefin competition assay. Antimicrobial Agents and Chemotherapy 1990, 34: 2184–2192.

    PubMed  Google Scholar 

  4. Catchpole CR, Wise R, Thornber D, Andrews JM: In vitro activity of L-627, a new carbapenem. Antimicrobial Agents and Chemotherapy 1992, 36: 1928–1934.

    PubMed  Google Scholar 

  5. Neu HC, Gu JW, Fang W, Chin NX: In vitro activity and β-lactamase stability of LJC 10,627. Antimicrobial Agents and Chemotherapy 1992, 36: 1418–1423.

    PubMed  Google Scholar 

  6. Yoshida M, Mitsuhashi S: In vitro antibacterial activity and beta-lactamase stability of the new carbapenem LJC 10,627. European Journal of Clinical Microbiology & Infectious Diseases 1990, 9: 625–629.

    Google Scholar 

  7. Petersen PJ, Jacobus NV, Weiss WJ, Testa RT: In vitro and in vivo activities of LJC 10,627, a new carbapenem with stability to dehydropeptidase I. Antimicrobial Agents and Chemotherapy 1991, 35: 203–207.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alonso, R., Fdez-Aranguiz, A., Colom, K. et al. In vitro activity of biapenem against beta-lactamase producingEnterobacteriaceae . Eur. J. Clin. Microbiol. Infect. Dis. 13, 820–822 (1994). https://doi.org/10.1007/BF02111342

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02111342

Keywords

Navigation